<unk> , sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection. The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.<unk>  was approved for medical use in the United States in December 2020.
Ansuvimab
Regdanvimab
Atoltivimab
Obiltoxaximab
Sotrovimab
Odesivimab
Nirsevimab
Lirentelimab